...
首页> 外文期刊>Online Journal of Animal and Feed Research >Treatment trials of epizootic lymphangitis with local medicinal plants: a review.
【24h】

Treatment trials of epizootic lymphangitis with local medicinal plants: a review.

机译:局部药用植物外膜淋巴管炎的治疗试验:综述。

获取原文
           

摘要

The aim of this paper was to review the use of local herbal medicines to treat Epizootic lymphangitis (EZL) and challenges related with safety, efficacy and quality control of herbal medicines. EZL has deleterious effect on both welfare and health of the horses and mules. In addition it has a serious negative impact on mainly the livelihoods of cart-horse owners/drivers. Basically, antifungal drugs for the treatment of EZL are costly and mostly unavailable in such areas especially in developing countries like Ethiopia. Medicinal herbs have a hopeful future since there are about half a million plants around the world, most of them have not yet been studied in medical practice, and current and future studies on medical activities can be effective in treating this disease. Furthermore, there is no gainsaying the fact that the requirements as well as the research protocols, standards and methods needed for the evaluation of the safety and efficacy of herbal medicines are much more complex than those required for conventional pharmaceuticals. These days, there are several trials on local plants like Xanthium stramorium (X. stramorium) , Combretum molle (C. molle) seed and Phytolacca dodecandra (P. dodecandra) extracts inhibited the growth of Histoplasma capsulatum var farciminosum (H. capsulatum var farciminosum). Among these, the aqueous and n-butanol extracts of P. dodecandra with minimum inhibitory concentration (MIC) of (0.078%-0.156%) and (0.039%–0.078%) respectively have been inhibiting the growth of H. capsulatum var. farciminosum . In vivo, over 58.3% horses with the disease responded to treatment then the other two plant extracts. In conclusion, P. dodecandra extracts showed a significant effect to inhibit the growth of H. capsulatum var farciminosum in vitro and EZL in vivo .
机译:本文的目的是审查局部草药的使用来治疗外膜淋巴管(EZL)和与草药的安全性,疗效和质量控制有关的挑战。 EZL对马匹和骡子的福利和健康有害影响。此外,它对推车 - 马所有者/司机的生计有严重的负面影响。基本上,用于治疗EZL的抗真菌药物在尤其是在埃塞俄比亚等发展中国家的地区,昂贵且通常不可用。药用草药有一个充满希望的未来,因为世界各地大约有五百万个植物,其中大多数尚未在医疗实践中进行过研究,对医疗活动的目前和未来的研究可以有效治疗这种疾病。此外,没有促进要求,评估草药的安全性和疗效所需的要求以及研究方案,标准和方法比常规药物所需的更复杂。如今,在Xanthium Stramorium(X. Stramorium),麦克风(C. molle)种子和Phytolacca dodecandra(p.Dodecandra)提取物等局部植物有几次试验抑制了组织胶囊液v var antciminosum的生长(H. capsulatum var farciminosum )。其中,具有最小抑制浓度(MIC)的p.Dodecandra的水和正丁醇提取物(0.078%-0.156%)和(0.039%-0.078%)分别抑制H. Capsulatum VAR的生长。胃霉素。在体内,超过58.3%的马匹与疾病的疾病反应治疗,然后是另外两种植物提取物。总之,P.Dodecandra提取物显示出抑制体内体外和EZL体外和EZL的H. Capsulatum Var Farciminosum的生长显着效果。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号